BrightSpring Health Services, Inc. (NASDAQ:BTSG) Given Consensus Rating of “Moderate Buy” by Brokerages

BrightSpring Health Services, Inc. (NASDAQ:BTSG) has been assigned an average recommendation of “Moderate Buy” from the fifteen analysts that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $19.42.

Several equities analysts recently commented on BTSG shares. UBS Group upped their target price on shares of BrightSpring Health Services from $22.00 to $30.00 and gave the company a “buy” rating in a research note on Wednesday, January 29th. KeyCorp started coverage on shares of BrightSpring Health Services in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. Mizuho boosted their price target on BrightSpring Health Services from $17.00 to $20.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. CJS Securities started coverage on BrightSpring Health Services in a report on Thursday, December 12th. They issued an “outperform” rating and a $27.00 price target for the company. Finally, Bank of America lifted their price objective on BrightSpring Health Services from $19.00 to $21.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th.

BrightSpring Health Services Stock Up 0.5 %

BTSG opened at $23.72 on Tuesday. BrightSpring Health Services has a twelve month low of $7.85 and a twelve month high of $24.82. The company has a debt-to-equity ratio of 1.63, a quick ratio of 0.97 and a current ratio of 1.35. The business has a 50 day moving average price of $18.91 and a 200 day moving average price of $16.10. The firm has a market cap of $4.13 billion and a P/E ratio of -91.23.

BrightSpring Health Services (NASDAQ:BTSG) last released its earnings results on Friday, November 1st. The company reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.07). The firm had revenue of $2.91 billion for the quarter, compared to analyst estimates of $2.72 billion. BrightSpring Health Services had a positive return on equity of 4.16% and a negative net margin of 0.38%. BrightSpring Health Services’s revenue for the quarter was up 28.8% on a year-over-year basis. Research analysts forecast that BrightSpring Health Services will post 0.59 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of BTSG. R Squared Ltd acquired a new position in BrightSpring Health Services during the fourth quarter worth approximately $74,000. Intech Investment Management LLC bought a new stake in shares of BrightSpring Health Services during the 3rd quarter worth about $159,000. nVerses Capital LLC lifted its position in BrightSpring Health Services by 195.8% during the third quarter. nVerses Capital LLC now owns 14,200 shares of the company’s stock worth $208,000 after acquiring an additional 9,400 shares during the last quarter. BNP Paribas Financial Markets boosted its holdings in shares of BrightSpring Health Services by 5.0% during the third quarter. BNP Paribas Financial Markets now owns 21,329 shares of the company’s stock worth $313,000 after acquiring an additional 1,011 shares during the period. Finally, SG Americas Securities LLC acquired a new position in shares of BrightSpring Health Services in the third quarter valued at approximately $360,000.

About BrightSpring Health Services

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.